IMV Technologies’ Acquisition Of GenetiRate inc.

IMV Technologies' Acquisition Of GenetiRate inc.

Gowling WLG and Faegre Drinker advised IMV Technologies on the deal. Hecker Pew PLLC advised the sellers.

IMV Technologies (IMV), the world leader in animal assisted reproduction biotechnologies, acquired GenetiRate inc., a US-based specialist in automated egg-sorting technology.

Generating 85% of turnover internationally, IMV Technologies, a French company, has subsidiaries and manufacturing facilities in Brazil, China, France, India, Italy, the Netherlands, Russia, Scotland, South Africa, and the United States, and an extensive network of distributors in more than 120 countries worldwide. The company operates leading brands in the areas of semen analysis, assisted reproduction, artificial insemination, and veterinary imaging. IMV’s Life Sciences division, CryoBio System, manufactures and distributes equipment and supplies for human assisted reproduction and biobanking.

Partner Barbara Jouffa (Picture) led on corporate aspects alongside senior associate Mathias Briatta, with partner Philippe Rousseau, leading on intellectual property matters.

The Faegre Drinker team included James Fischer, Alexander Meiseles, Madison Riede.

The Hecker Pew PLLC team included Will Pew.

Involved fees earner: James Fischer – Faegre Drinker Biddle & Reath LLP; Alexander Meiseles – Faegre Drinker Biddle & Reath LLP; Madison Riede – Faegre Drinker Biddle & Reath LLP; Mathias Briatta – Gowling WLG; Barbara Jouffa – Gowling WLG; Philippe Rousseau – Gowling WLG; Will Pew – Hecker Pew PLLC;

Law Firms: Faegre Drinker Biddle & Reath LLP; Gowling WLG; Hecker Pew PLLC;

Clients: GenetiRate Inc.; IMV Technologies SA;

Naoual Sadouqi

Author: Naoual Sadouqi